by Kerry Myers | Aug 10, 2023 | Case Study
A novel approach to wallet card design & manufacturing helps an innovator avoid costly Phase III study delays. A global biopharmaceutical company sponsored a Phase III, randomized, double-blind study to gain approval for extending its commercially available...